NOCT vs. CPSP

Last updated Jun 4, 2026

NOCT (Innovator Growth-100 Power Buffer ETF - October) and CPSP (Calamos S&P 500 Structured Alt Protection ETF - April) are both exchange-traded funds - NOCT is a Defined Outcome fund actively managed by Innovator, while CPSP is a S&P 500 fund actively managed by Calamos. Both are actively managed. Over the past year, NOCT returned 17.36% vs 7.13% for CPSP. A 0.66 correlation means they provide meaningful diversification when combined. NOCT charges 0.79%/yr vs 0.69%/yr for CPSP.

Performance

NOCT vs. CPSP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Innovator Growth-100 Power Buffer ETF - October (NOCT) and Calamos S&P 500 Structured Alt Protection ETF - April (CPSP). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, NOCT achieves a 7.61% return, which is significantly higher than CPSP's 3.18% return.

NOCT

• 1D: -0.12%
• 1M: 2.54%
• YTD: 7.61%
• 6M: 7.69%
• 1Y: 17.36%
• 3Y*: 14.98%
• 5Y*: 10.46%
• 10Y*: —

CPSP

• 1D: 0.00%
• 1M: 0.60%
• YTD: 3.18%
• 6M: 3.74%
• 1Y: 7.13%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

NOCT vs. CPSP - Yearly Performance Comparison

	2026 (YTD)	2025
NOCT Innovator Growth-100 Power Buffer ETF - October	7.61%	16.04%
CPSP Calamos S&P 500 Structured Alt Protection ETF - April	3.18%	5.46%

Correlation

The correlation between NOCT and CPSP is 0.63, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.63
Correlation (All Time) Calculated using the full available price history since Apr 2, 2025	0.66

The correlation between NOCT and CPSP has been stable across timeframes, ranging from 0.63 to 0.66 - a consistent structural relationship.

Return for Risk

NOCT vs. CPSP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NOCT

NOCT Risk / Return Rank: 71
NOCT Sharpe Ratio Rank: 71
NOCT Sortino Ratio Rank: 72
NOCT Omega Ratio Rank: 78
NOCT Calmar Ratio Rank: 60
NOCT Martin Ratio Rank: 74

CPSP

CPSP Risk / Return Rank: 98
CPSP Sharpe Ratio Rank: 98
CPSP Sortino Ratio Rank: 99
CPSP Omega Ratio Rank: 98
CPSP Calmar Ratio Rank: 98
CPSP Martin Ratio Rank: 99

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NOCT vs. CPSP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Innovator Growth-100 Power Buffer ETF - October (NOCT) and Calamos S&P 500 Structured Alt Protection ETF - April (CPSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NOCT	CPSP	Difference
Sharpe ratio: Return per unit of total volatility	2.31	5.08	-2.76
Sortino ratio: Return per unit of downside risk	3.26	9.15	-5.89
Omega ratio: Gain probability vs. loss probability	1.46	2.31	-0.85
Calmar ratio: Return relative to maximum drawdown	2.99	19.11	-16.12
Martin ratio: Return relative to average drawdown	13.90	96.35	-82.45
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NOCT vs. CPSP - Sharpe Ratio Comparison

The current NOCT Sharpe Ratio is 2.31, which is lower than the CPSP Sharpe Ratio of 5.08. The chart below compares the historical Sharpe Ratios of NOCT and CPSP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	NOCT	CPSP	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.31	5.08	-2.76
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.96	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	1.01	3.17	-2.16

Drawdowns

NOCT vs. CPSP - Drawdown Comparison

The maximum NOCT drawdown since its inception was -16.21%, which is greater than CPSP's maximum drawdown of -1.73%. Use the drawdown chart below to compare losses from any high point for NOCT and CPSP.

Drawdown Indicators

	NOCT	CPSP	Difference
Max Drawdown Largest peak-to-trough decline	-16.21%	-1.73%	-14.48%
Max Drawdown (1Y) Largest decline over 1 year	-5.84%	-0.37%	-5.47%
Max Drawdown (3Y) Largest decline over 3 years	-12.70%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-16.21%	—	—
Current Drawdown Current decline from peak	-0.16%	0.00%	-0.16%
Average Drawdown Average peak-to-trough decline	-2.34%	-0.08%	-2.26%
Ulcer Index Depth and duration of drawdowns from previous peaks	1.25%	0.07%	+1.18%

Volatility

NOCT vs. CPSP - Volatility Comparison

Innovator Growth-100 Power Buffer ETF - October (NOCT) has a higher volatility of 1.01% compared to Calamos S&P 500 Structured Alt Protection ETF - April (CPSP) at 0.32%. This indicates that NOCT's price experiences larger fluctuations and is considered to be riskier than CPSP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NOCT	CPSP	Difference
Volatility (1M) Calculated over the trailing 1-month period	1.01%	0.32%	+0.69%
Volatility (6M) Calculated over the trailing 6-month period	5.90%	0.84%	+5.06%
Volatility (1Y) Calculated over the trailing 1-year period	7.55%	1.42%	+6.13%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	10.93%	2.37%	+8.56%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	11.19%	2.37%	+8.82%

NOCT vs. CPSP - Expense Ratio Comparison

NOCT has a 0.79% expense ratio, which is higher than CPSP's 0.69% expense ratio.

Dividends

NOCT vs. CPSP - Dividend Comparison

Neither NOCT nor CPSP has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019
CPSP Calamos S&P 500 Structured Alt Protection ETF - April	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOCT Innovator Growth-100 Power Buffer ETF - October	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.07%

Frequently Asked Questions

Can I hold both NOCT and CPSP in my portfolio?

NOCT and CPSP have a correlation of 0.63, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, NOCT or CPSP?

NOCT has higher volatility (1.01%) compared to CPSP (0.32%). In terms of maximum drawdown, NOCT dropped -16.21% vs CPSP's -1.73%.

Which ETF is better, NOCT or CPSP?

On 1-year performance, NOCT leads with 17.36% vs 7.13% for CPSP. On fees, CPSP is cheaper at 0.69% per year. On volatility, CPSP has been the lower-risk option at 0.32%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, NOCT or CPSP?

Over the 1-year period, NOCT has performed better with a 17.36% return vs 7.13%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, NOCT or CPSP?

CPSP is cheaper with a 0.69% expense ratio, compared with 0.79% for NOCT.

Which ETF pays a higher dividend yield, NOCT or CPSP?

NOCT and CPSP have nearly identical dividend yields, around 0.00%.

What is the main difference between NOCT and CPSP?

NOCT is categorized as Defined Outcome, while CPSP is S&P 500. They also come from different issuers: Innovator and Calamos. Their fees differ too: 0.79% for NOCT and 0.69% for CPSP.

Which has better risk-adjusted returns?

CPSP currently has the higher Sharpe Ratio (5.08 vs 2.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.